NasdaqGS:UTHRBiotechs
Assessing United Therapeutics (UTHR) Valuation After Strong Recent Share Price Momentum
United Therapeutics (UTHR) has attracted investor attention after recent share price moves, with the stock showing an 8.9% return over the past month and 21.8% over the past 3 months.
See our latest analysis for United Therapeutics.
At a share price of $569.11, United Therapeutics has paired an 8.9% 1 month share price return with a 1 year total shareholder return of 89.2%. Recent momentum has been building on already solid longer term gains.
If you are comparing United Therapeutics with...